Cocaine use is associated with worse outcomes in patients treated with thoracic endovascular repair for type B aortic dissection

Journal of Vascular Surgery
Halim YammineFrank R Arko

Abstract

To describe and compare the clinical and anatomical characteristics and outcomes of patients with and without known cocaine use who underwent thoracic endovascular repair for type B aortic dissections. Between January 2012 and January 2017, 186 patients underwent thoracic endovascular repair for type B aortic dissection at our institution. Clinical data and anatomical characteristics were collected under an institutional review board-approved protocol. Survival, reintervention, complications, and characteristics of dissection were compared between patients with cocaine use (C+; n = 14) and those with no known cocaine use (C-; n = 172). Cocaine users were more likely to be young African American males who smoked. They tended to present with more extensive dissections as evidenced by larger false lumen diameters. They also had higher rates of endoleaks and more reinterventions. These results suggest that special care should be taken to provide close follow-up for these patients.

References

Dec 1, 1998·American Journal of Hypertension·C S BrecklinG Dunea
May 20, 1999·The New England Journal of Medicine·C A NienaberA Pierangeli
May 20, 1999·The New England Journal of Medicine·M D DakeD C Miller
Jul 3, 1999·The Annals of Thoracic Surgery·J A ElefteriadesJ A Rizzo
Feb 24, 2000·JAMA : the Journal of the American Medical Association·P G HaganK A Eagle
Apr 3, 2002·Circulation·Kim A EagleUNKNOWN International Registry for Aortic Dissection (IRAD) Investigators
Apr 3, 2002·Circulation·Priscilla Y HsueDavid D Waters
Jul 29, 2006·The Journal of Thoracic and Cardiovascular Surgery·Rossella FattoriUNKNOWN Talent Thoracic Retrospective Registry
Sep 5, 2006·Journal of Vascular Surgery·Shane S ParmerJoseph E Bavaria
Aug 21, 2007·Journal of the American College of Cardiology·Jong-Min SongJae-Kwan Song
Sep 11, 2007·Journal of Vascular Surgery·Jonathan C DanielScott A LeMaire
Dec 7, 2007·The Canadian Journal of Cardiology·Sarabjeet SinghSandeep Khosla
Aug 8, 2009·The Journal of Thoracic and Cardiovascular Surgery·Gabriele PiffarettiPatrizio Castelli
Nov 17, 2009·The Journal of Thoracic and Cardiovascular Surgery·Shang Dong XuZhao Guang Zhang
Mar 18, 2010·Vascular Medicine·Avneet SinghMartin A Alpert
Dec 16, 2010·Circulation·Bryan G SchwartzRobert A Kloner
Sep 2, 2011·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·S G ThrumurthyM M Thompson
Aug 8, 2013·Circulation. Cardiovascular Interventions·Christoph A NienaberUNKNOWN INSTEAD-XL trial
May 20, 2014·The American Journal of Medicine·Joshua H DeanEduardo Bossone
Oct 13, 2014·The Journal of Thoracic and Cardiovascular Surgery·G Chad Hughes
Feb 7, 2015·Trends in Cardiovascular Medicine·Rachel V StankowskiShereif H Rezkalla
Apr 29, 2015·The Journal of Emergency Medicine·Rahman ShahM Rehan Khan
Sep 6, 2015·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Michal NozdrzykowskiChristian D Etz
Apr 14, 2016·Vascular Medicine·Foeke Jh NautaJames B Froehlich
Jul 1, 2016·Asian Cardiovascular & Thoracic Annals·Hailei LiStephen W Cheng
Apr 2, 2017·Atherosclerosis·Keren BachiNelly Alia-Klein
Feb 6, 2018·Journal of Vascular Surgery·Halim YammineFrank R Arko

❮ Previous
Next ❯

Citations

Sep 24, 2020·The Journal of Cardiovascular Surgery·Eric Y PruittGilbert R Upchurch
Aug 25, 2021·Annals of Vascular Surgery·Juliet Blakeslee-CarterGraeme E McFarland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.